Skip to main content
. 2019 Jan 29;1:100007. doi: 10.1016/j.jvacx.2019.100007

Table 2.

Herpes zoster incidence in unvaccinated populations (per 1000 person-years).

Risk factor Herpes zoster incidence (/1000 person-years) [95% CI]a
General population
Overall 9·34 [8·78; 9·90]
Routine cohort 9·45 [8·72; 10·18]
Catch-up cohort 9·20 [8·55; 9·85]
Female 10·55 [9·80; 11·3]
Male 8·14 [7·49; 8·79]
Caucasian 9·53 [8·95; 10·10]
Non-Caucasian 5·79 [4·15; 7·43]
Non-smoker 9·66 [8·94; 10·39]
Ex-smoker 9·36 [8·54; 10·17]
Smoker 8·01 [6·83; 9·20]



Patient populations
Asthma 11·20 [9·94; 12·45]
Immunocompromised 15·48 [12·17; 18·79]
Immunosuppressed 14·23 [10·92; 17·55]
History of herpes zoster 10·78 [9·39; 12·17]
a

Derived from simplified main effects model, assuming age, gender and ethnicity distribution as well as smoking behaviour reflective of the UK population. Assuming no other herpes zoster risk factors are present.